Comprehensive-Care for Multimorbid Adults Effectiveness Study

Meir Medical Center1,800 enrolled

Overview

This study is intended to examine whether directed care of a nurse working jointly with the patient's primary care physician, including a comprehensive assessment, creation of a tailored care plan, proactive follow-up, self management support and caregiver support and care coordination, can reduce hospital admissions for patients with multiple chronic conditions.

Patients with multi-morbidities pose a significant challenge for healthcare organizations because they require continuity of care among a wide range of long-term therapeutic paradigms for many different types of diseases. The current study is based on a treatment model entailing a nurse-primary care physician team to provide care for patients with multiple morbidities. Patients in the intervention group who agreed and signed the consent form to participate in the study will receive treatment by the physician - nurse team in accordance with the components of the Clalit's Comprehensive Care for Mutlimorbid Adults Project model. Components of the intervention include: 1. Comprehensive assessment of the patient's and family's needs 2. Coordinated care plan based on integrated care guides 3. "Multimorbid Action Plan" for patients 4. All-inclussive patient centered care and caregiver support 5. Proactive monitoring according to the plan. Patients in the control groups will receive usual care in their primary care clinics. The Usual Care Survey control group will complete study questionnaires at 6, 12 and 24 months after enrollement. The Usual Care Blinded group will be assessed only retrospectively based on deidentified information from Clalit's admistrative databases.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

1,800

Conditions

Chronic Disease

Interventions

Nurse-physician comprehensive careOTHER

Components of the intervention include: 1. Complete assessment of the patient's and family's needs conducted by the nurse. 2. Comprehensive treatment program developed by the nurse and in consultation with the primary care physician. 3. "Multimorbid care plan" integrating all care aspects. 4. "Action Plan" for patients, supporting self management 5. Proactive monitoring according to the plan.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 95 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ACG system high risk probabilty score - 4% Highest Risk Score * Age 18 and older * 2 or more chronic conditions Exclusion Criteria: * Patients already included in a controlled disease management program (e.g., COPD disease management and telehealth). * Participation in any medical research. * Confined to bed. * Inpatient nursing care, nursing homes. * Kidney, liver or heart transplant patients. * Active (receipt of oncology chemotherapy , radiotherapy or other oncology treatment during the past 3 years). * Dialysis patients. * Clalit Healthcare Services employees. * Patients with major active mental illness, such as schizophrenia. * Cognitive failure. * Non Hebrew speaking patients without Hebrew speaking primary informal caregiver. * Bedridden patients * Housebound patients

Locations (13)

Ashdod A

Ashdod, Israel

Ashdod D

Ashdod, Israel

Azur

Azor, Israel

Arlozorov

Bat Yam, Israel

Outcomes

Primary Outcomes

Percent change in admissions for ambulatory care sensetive conditions

Ambulatory Care Sensitive Conditions will be defined by ICD-9 codes, based on the classification published by: Ansari, Barbetti, Carson, Auckland, \& Cicuttini, 2003 (adapted from Weissman JS, Gatsonis C, Epstein AM ,1992; Millman M, ed. 1993)

Time frame: At enrollment and within 12 months and 24 months after enrollment

Secondary Outcomes

Emergency 30-day readmissions

Emergency readmissions are defined as an urgent (via the Emergency Room) admission of one night or longer, following an index admission that lasted 2 nights or longer, in the prior 30 days.

Time frame: 30 days post an index admission

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.